Our custom services. Your trusted CRO partner.
At Aquila, we’re proud to provide pre-clinical immunology, immuno-oncology, specialist histology and neuroscience services.
We can help you with both in vitro and in vivo proof-of-concept and mode-of-action studies in immunology, oncology and neurodegenerative diseases as well as biomarker discovery and target expression for other immune-related diseases.
Our expert scientists work closely with you to tailor our services to answer your scientific questions. If required, we can develop custom immune cell-based assays ahead of compound screening to ensure the robustness of your drug discovery platform.
Through our own investment on-site, access to the University of Edinburgh’s facilities, and as part of Concept Life Sciences, we are uniquely positioned to incorporate cutting-edge technology into our service offerings.
Biological Imaging Services
- Multiple parameter/colour flow cytometry Fortessa LSRII (5-laser)
- Multidimensional confocal laser scanning microscopy
- Fluorescent microscopy
- Perkin Elmer Operetta high content imaging system
- Slide scanning
- Transmission and scanning electron microscopes
- Live cell and in vivo imaging
Molecular Biology Analyses
- Nucleic acid sequencers
- High-throughput qPCR
- Microarray scanner
- Single-cell RNA sequencing
- Surface Plasma Resonance (SPR)
Whatever your requirements, we are committed to delivering you a superior quality outsourcing service with high attention to detail. By saving you time and increasing the success of your lead candidate, we support your best route to clinic.
Please get in touch to learn more about our wide range of CRO services.
We can help you understand your target's and/or compound's mechanism of action to progress your drug discovery pipeline.
Understanding the remyelination efficiency of your drug candidate in three dimensions with a realistic cell structure can help you on the best route to clinic.
Immuno-oncology is an exciting and progressing area of research that uses manipulation of the immune system to successfully target cancer.
Microglia are increasingly popular as a therapeutic target for central nervous system (CNS) disorders, including multiple sclerosis and spinal cord injury.
We offer a complete range of specialist histology and molecular tissue probing services, including multiplex histology and RNAscope.
Understanding how to use Oligodendrocyte Precursor Cells (OPCs) to enhance remyelination in multiple sclerosis is key to bringing new treatments to the clinic.
We share expertise to help you understand your drug candidates, gathering robust data to drive confident decision making throughout your CNS drug discovery process.